HUBUNGAN TINGKAT PENGETAHUAN DENGAN KESIAPAN VAKSINASI COVID-19 PADA USIA PRODUKTIF DI DESA SUKABUNGAH

  • Baltasar Serilus Sanggu Dedu Institusi Pendidikan
  • Ami Nuryani
  • Dinda Nur Fajri Hidayati Bunga

Abstract

Background: At the end of 2019, there was a pandemic that originated from China, precisely in the city of Wuhan. This pandemic is known as COVID-19. COVID-19 is caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). When compared to SARS in 2003 and MERS in 2012, the spread of this pandemic was much faster. One of the efforts to control the pandemic that is still spreading is the COVID-19 vaccine. Vaccination is an effective prevention of disease transmission and it is the government's obligation to ensure the availability of vaccines. Those who were living in Indonesia aged ³ 18 years is a priority group receiving the vaccine.

Research Objectives: The aim of this study is to identify the relationship between knowledge level and COVID-19 vaccination readiness at productive age in Sukabungah village 2021.

Research Methods: This research method is a quantitative design using aanalytic research design cross sectional. The population of this study is the productive age community in Sukabungah Village, using the cluster random sampling technique.

Research Results : Based on the results of statistical analysis using the chi square test , theobtained p value of 0.000 0.05 was. This shows that H0 is rejected.

Conclusion : There is a relationship between the level of knowledge and the readiness of COVID-19 vaccination at productive age in Sukabungah Village in 2021.

References

[1]. Aditama, T. Y. (2020). COVID-19 dalam Tulisan Prof. Tjandra. Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan (LPB).
[2]. Akbar, S. &. (2021). Pelayan Publik Kecamatan Bojongmangu Jalani Vaksinasi Covid-19. Bekasikab.Go.Id.
[3]. Astuti, A. D. W. (2010). Hubungan Tingkat Pengetahuan Tentang Menstruasi Dengan Kesiapan Menghadapi Menarche Pada Siswi Kelas 1 Di Smp Theresiana Jambu, Semarang, Jawa Tengah. Sekolah Tinggi Ilmu Kesehatan Jenderal Ahmad Yani.
[4]. Bekasi, D. K. (2021). Gugus Tugas Percepatan Penanganan Covid-19 Kabupaten Bekasi. Pikokabsi.Bekasikab.Go.Id. https://pikokabsi.bekasikab.go.id
[5]. Citrawathi, D. M. (2014). Pengembangan Model Pendidikan Kesehatan Integratif dan Kolaboratif di Sekolah. Seminar Nasional FMIPA UNDIKSHA IV, 223–230.
[6]. Covid-19, T. K. K. P. (2021). Pasien Sembuh Terus Meningkat Mencapai 1.606.611 Orang. Covid19.Go.Id. https://covid19.go.id/p/berita/pasien-sembuh-terus-meningkat-mencapai-1606611-orang
[7]. Darmono. (2014). VIRUS : Mikroorganisme Terkecil yang Menyebabkan Penyakit. Penerbit Universitas Indonesia (UI-Press).
[8]. Dharma, K. K. (2013a). Metodologi Penelitian Keperawatan. Trans Info Media.
[9]. Dharma, K. K. (2013b). Metodologi Penelitian Keperawatan (Panduan Melaksanakan dan Menerapkan Hasil Penelitian). CV. Trans Info Media.
[10]. Farmasetika, M., Farmasi, S., Farmasi, F., Padjadjaran, U., Farmasi, F., & Padjadjaran, U. (2020). Perkembangan Teknologi Terkini dalam Mempercepat Produksi Vaksin Covid-19. 5(5), 204–217.
[11]. Febriyanti, N., Choliq, M. I., & Mukti, A. W. (2021). Hubungan Tingkat Pengetahuan dan Kesediaan Vaksinasi Covid-19 Pada Warga Kelurahan Dukuh Menanggal Kota Surabaya. 36–42.
[12]. Harimurti, K. (2021). Penapisan Untuk Vaksinasi Covid-19. https://persi.or.id/wp-content/uploads/2021/02/paparan-kuntjoro-harimurti-130221.
[13]. Hastono, S. P. (2006). Analisis Data. Universitas Indonesia.
[14]. Jabar, D. (2021). Sebaran Kasus Covid-19 di Jawa Barat. Pikobar.Jabarprov.Go.Id. https://pikobar.jabarprov.go.id/distribution-case
[15]. Kemenkes RI. (2020). FAQ Kementerian Kesehatan Republik Indonesia. Kemkes.Go.Id. https://www.kemkes.go.id/folder/view/full-content/structure-faq.html
[16]. Kemenkes RI. (2021a). Masyarakat Indonesia Sambut Baik Vaksinasi Covid-19. Promkes.Kemkes.Go.Id. https://promkes.kemkes.go.id/masyarakat-indonesia-sambut-baik-vaksinasi-covid-19
[17]. Kemenkes RI. (2021b). Tanya Jawab Vaksin COVID-19. Covid19.Go.Id.
[18]. Kemenkes RI. (2021c). Vaksinasi COVID-19 Nasional. Vaksin.Kemkes.Go.Id. https://vaksin.kemkes.go.id/#/vaccines
[19]. Kemenkes RI 2012. (2012). Profil Kesehatan Indonesia 2011. In Profil Kesehatan Indonesia. file:///C:/Users/ASUS/Downloads/profil-kesehatan-indonesia-2011 (1).pdf
[20]. Kementerian Kesehatan Republik Indonesia. (n.d.).
[21]. Kementerian Kesehatan Republik Indonesia. (2020). Survei Penerimaan Vaksin COVID-19 di Indonesia. Satuan Gugus Tugas Penanganan COVID-19, November, 1–26.
[22]. Kementerian Kesehatan Republik Indonesia. (2021). Question ( Faq ) Pelaksanaan Vaksinasi Covid-. 1–16. https://kesmas.kemkes.go.id/assets/uploads/contents/others/FAQ_VAKSINASI_COVID__call_center.pdf
[23]. Koesnoe, S. (2021). Teknis Pelaksanaan Vaksin Covid dan Antisipasi KIPI. SatGas Imunisasi Dewasa PB PAPDI PP Perhimpunan Alergi Imunologi Jakarta Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia Cab. Bogor.
[24]. Komini Nasional Etik Penelitian Kesehatan. (2011). Pedoman Nasional Etik Penelitian Kesehatan 2011. Litbang Kementrian Kesehatan, 1–134. http://www.ke.litbang.kemkes.go.id/kom14/wp-content/uploads/2017/12/Pedoman-Nasional-Etik-Penelitian-Kesehatan-2011-Unedited-Version.pdf
[25]. Makmun, A., & Hazhiyah, S. F. (2020). Tinjauan Terkait Pengembangan Vaksin Covid 19. Molucca Medica, 13, 52–59. https://doi.org/10.30598/molmed.2020.v13.i2.52
[26]. Marwan. (2021). Peran Vaksin dalam Penanganan Pandemi C19.
[27]. Masturoh, Imas & T, N. A. (2018). Metodologi Penelitian Kesehatan. Kementrian Kesehatan RI.
[28]. Muchtaruddin Mansyur. (2021). Vaksinasi COVID-19 bagi Pekerja, Harapan Pulihnya Produktivitas. Journal Of The Indonesian Medical Association, 71(1), 1–4. https://doi.org/10.47830/jinma-vol.71.1-2021-534
[29]. Nadia, S. (2020). Kebijakam Pelaksanaan Vaksinasi COVID-19. Direktorat Jenderal Pencegahan Dan Pengendalian Penyakit Kementerian Kesehatan, 1–46.
[30]. Notoatmodjo, S. (2018). Metodologi penelitian kesehatan. PT. Rineka Cipta.
[31]. Nursalam. (2015). Metodologi Penelitian Ilmu Keperawatan : Pendekatan Praktis (3rd ed.). Salemba Medika.
[32]. Pusat, P., Gerontologi, P., & Indonesia, M. (n.d.). Rekomendasi dan Skrining pada Pemberian Vaksin COVID-19 untuk Lansia.
[33]. RI, K. (2021). Data Sebaran. Covid19.Go.Id. https://www.covid19.go.id
[34]. Siyoto, Sandu & Sodik, M. A. (2015). Dasar Metodologi Penelitian. Literasi Media Publishing.
[35]. SS, E., AO, O., RY, A., KA, O., EO, O., AJ, N., EN, A., & CB, E. (2020). Assessment of Knowledge, Perception and Readiness of Nigerians to Participate in the COVID-19 Vaccine Trial. International Journal of Vaccines and Immunization, 4(1), 1–13. https://doi.org/10.16966/2470-9948.123
[36]. Suganda, S. (2021). 200 Lansia dari 6 Desa di Bojongmangu Ikuti Vaksinasi Covid-19. Bekasikab.Go.Id.
[37]. Syamaidzar, S. (2020). Review Vaksin Covid-19. Research Gate, July, 1–15.
[38]. WHO. (2021). WHO Coronavirus (COVID-19) Dashboard. Covid19.Who.Int. https://covid19.who.int
[39]. Yuliana, Y. (2020). Corona virus diseases (Covid-19): Sebuah tinjauan literatur. Wellness And Healthy Magazine, 2(1), 187–192. https://doi.org/10.30604/well.95212020
[40]. Yuningsih, R. (2020). Uji Klinik Coronavac dan Rencana Vaksinasi COVID-19 Massal Di Indonesia. Puslit BKD DPR RI, vol.XII(16), 13–18.
Published
2022-02-28